The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters

Journal of Infectious Diseases

Volumn 193, Issue 1, 2006, Pages 155-162

  Ghosh, Kashinath ^a,c   Wu, Wenhui ^a   Antoine, Adrienne D ^a   Bottazzi, Maria Elena ^a   Valenzuela, Jesus G ^b   Hotez, Peter J ^a   Mendez, Susana ^a,d  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BENZIMIDAZOLE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; MEBENDAZOLE; MESSENGER RNA; PARASITE ANTIGEN; PROTEIN AY ASP 2; PYRANTEL EMBONATE; QUIL A; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANCYLOSTOMA CEYLANICUM; ANCYLOSTOMIASIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HAMSTER; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANCYLOSTOMA; ANCYLOSTOMIASIS; ANIMALS; ANTIBODIES, HELMINTH; CRICETINAE; HELMINTH PROTEINS; HUMANS; IMMUNIZATION; MESOCRICETUS; RECOMBINANT FUSION PROTEINS; SAPONINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 29744461099     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498528     Document Type: Article

References (50)

1. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003; 19:547-51.
2. Bethony J, Chen J, Lin S, et al. Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. Clin Infect Dis 2002; 35:1336-44.
3. Albonico M, Smith PG, Ercole E, et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995; 89:538-41.
4. Albonico M, Bickle Q, Ramsan M, Montresor A, Savioli L, Taylor M. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Health Organ 2003; 81:343-52.
5. Albonico M. Methods to sustain drug efficacy in helminth control programmes. Acta Trop 2003; 86:233-42.
6. Albonico M, Bickle Q, Haji HJ, et al. Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections. Trans R Soc Trop Med Hyg 2002; 96:685-90.
7. Hotez PJ, Zhan B, Bethony JM, et al. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol 2003; 33:1245-58.
8. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao SH. Hookworm infection. N Engl J Med 2004; 351:799-807.
9. Onyemelukwe GC, Musa BO. T-lymphocyte subsets in patients with hookworm infection in Zaria, Nigeria. Afr J Med Med Sci 2001; 30:255-9.
10. Olatunde BO, Onyemelukwe GC. Immunosuppression in Nigerians with hookworm infection. Afr J Med Med Sci 1994; 23:221-5.
11. Kalinkovich A, Weisman Z, Greenberg Z, et al. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 1998; 114:414-21.
12. Geiger SM, Massara CL, Bethony J, Soboslay PT, Correa-Oliveira R. Cellular responses and cytokine production in post-treatment hookworm patients from an endemic area in Brazil. Clin Exp Immunol 2004; 136:334-40.
13. Pit DS, Polderman AM, Baeta S, Schulz-Key H, Soboslay PT. Parasite-specific antibody and cellular immune responses in human infected with Necator americanus and Oesophagostomum bifurcum. Parasitol Res 2001; 87:722-9.
14. Menon S, Bhopale MK. Ancylostoma ceylonicum (Looss, 1911) in golden hamsters (Mesocricetus auratus): pathogenicity and humoral immune response to a primary infection. J Helminthol 1985; 59:143-6.
15. Ray DK, Bhopale KK. Complete development of Ancylostoma ceylonicum (Looss, 1911) in golden hamsters, Mesocricetus auratus. Experientia 1972; 28:359-61.
16. Gupta S, Srivastava JK, Katiyar JC. Ancylostoma ceylonicum: migratory behaviour in golden hamsters after oral and parenteral infection. Ann Trop Med Parasitol 1987; 81:421-8.
17. Garside P, Behnke JM. Ancylostoma ceylonicum in the hamster: observations on the host-parasite relationship during primary infection. Parasitology 1989; 98:283-9.
18. Mendez S, Valenzuela JG, Wu W, Hotez PJ. Characterization of the immune response against Ancylostoma ceylonicum in the Golden Syrian hamster: host cytokine production, lymphoproliferation, and antibody responses during the course of the infection. Infect Immun 2005; 73:3402-7.
19. Behnke IM, Guest J, Rose R. Expression of acquired immunity to the hookworm Ancylostoma ceylonicum in hamsters. Parasite Immunol 1997; 19:309-18.
20. Bungiro RD Jr, Anderson BR, Cappello M. Oral transfer of adult Ancylostoma ceylonicum hookworms into permissive and nonpermissive host species. Infect Immun 2003; 71:1880-6.
21. Ali F, Brown A, Stanssens P, Timothy LM, Soule HR, Pritchard DI. Vaccination with neutrophil inhibitory factor reduces the fecundity of the hookworm Ancylostoma ceylonicum. Parasite Immunol 2001; 23:237-49.
22. Bungiro RD Jr, Greene J, Kruglov E, Cappello M. Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylonicum. J Infect Dis 2001; 183:1380-7.
23. Goud GN, Zhan B, Ghosh K, et al. Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylonicum. J Infect Dis 2004; 189:919-29.
24. Mendez S, Zhan B, Goud G, et al. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylonicum. Vaccine 2005; 23:3123-30.
25. Duerr HP, Dietz K, Schulz-Key H, Buttner DW, Eichner M. Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. Trans R Soc Trop Med Hyg 2003; 97:242-50.
26. Faquim-Mauro EL, Macedo MS. The immunosuppressive activity of Ascaris suum is due to high molecular weight components. Clin Exp Immunol 1998; 114:245-51.
27. Attallah AM, Smith AH, Murrell KD, et al. Characterization of the immunosuppressive state during Schistosoma mansoni infection. J Immunol 1979; 122:1413-20.
28. O'Neill SM, Brady MT, Callanan JJ, et al. Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol 2000; 22:147-55.
29. Soares MF, Oliveira EB, Mota I, Macedo MS. Suppression of IgE antibody production by Ascaris suum extract: characterization of suppressive component(s). Braz J Med Biol Res 1988; 21:527-9.
30. Borkow G, Leng Q, Weisman Z, et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000; 106:1053-60.
31. Kullberg MC, Pearce EJ, Hieny SE, Sher A, Berzofsky JA. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a nonparasite antigen. J Immunol 1992; 148:3264-70.
32. Stewart GR, Boussinesq M, Coulson T, Elson L, Nutman T, Bradley JE. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol 1999; 117:517-23.
33. Kilian HD, Nielsen G. Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop Med Parasitol 1989; 40:445-53.
34. Bentwich Z. Concurrent infections that rise the HIV viral load. J HIV Ther 2003; 8:72-5.
35. Bassily S, Kotkat A, Hyams KC, et al. Immunogenicity of recombinant hepatitis B vaccine among infants of mothers with active schistosomiasis. Am J Trop Med Hyg 1997; 57:197-9.
36. Cooper PJ, Mancero T, Espinel M, et al. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response. J Infect Dis 2001; 183:1662-8.
37. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996; 173:269-72.
38. Nookala S, Srinivasan S, Kaliraj P, Narayanan RB, Nutman TB. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun 2004; 72:2598-604.
39. Cooper PJ, Espinel I, Wieseman M, et al. Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect Immun 1999; 67:5951-7.
40. Cooper PJ, Chico M, Sandoval C, et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001; 69:1574-80.
41. Visen PK, Katiyar JC, Sen AB. Studies on infectivity, longevity and fecundity of Ancylostoma ceylonicum in golden hamsters. J Helminthol 1984; 58:159-63.
42. Mendez S, Zhan B, Goud G, et al. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylonicum. Vaccine 2005; 23:3123-30.
43. Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 1998; 178:1133-8.
44. Quinnell RJ, Woolhouse ME, Walsh EA, Pritchard DI. Immunoepidemiology of human necatoriasis: correlations between antibody responses and parasite burdens. Parasite Immunol 1995; 17:313-8.
45. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
46. + T cells from microfilaraemic subjects compared with amicrofilaraemics. Clin Exp Immunol 1997; 108:272-8.
47. Quinnell RJ, Pritchard DI, Raiko A, Brown AP, Shaw MA. Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J Infect Dis 2004; 190:430-8.
48. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 1996; 26:1365-70.
49. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol 2001; 123:219-25.
50. Cooper PJ, Chico ME, Losonsky G, et al. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis 2000; 182:1199-206.